Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.
Other companies in Y-mAbs Therapeutics’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT) and Pharming (NASDAQ:PHAR).
Y-mAbs Therapeutics has a consensus price target of $19.17.
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $12.95 last updated September 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Y-mAbs Therapeutics.
Y-mAbs Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Y-mAbs Therapeutics.
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.